Thyroid cancer is the most common malignancy of the endocrine system. The diagnosis of
thyroid nodules, made by neck examination and ultrasonography, is a common event …

Familial thyroid cancer has become a well‐recognized entity in patients with thyroid cancer
originating from follicular cells, that is, nonmedullary thyroid carcinoma. The diagnosis of …

There are several definitions of biomarkers. A biomarker is a characteristic that can be
objectively measured and evaluated as an indicator of a physiological as well as a …

Purpose: Medullary thyroid carcinoma (MTC) is a manifestation of multiple endocrine
neoplasia type 2 (MEN2) syndromes caused by germline, activating mutations in the RET …

Medullary thyroid carcinoma (MTC) is a rare thyroid carcinoma with a variable clinical
behavior. Potential clinical and pathological prognostic markers have been investigated, but …

Results: A total of 802 DEGs were obtained between the THCA group and the N group.
These DEGs were mainly enriched in pathways such as lysine degradation. From the PPI …

Background and Objectives: Medullary thyroid carcinoma (MTC) accounts for 1–2% of all
thyroid malignancies, and it originates from parafollicular “C” cells. Carcinoembryonic …

Medullary thyroid carcinoma (MTC) is a rare calcitonin producing neuroendocrine tumour
that originates from the parafollicular C-cells of the thyroid gland. The RET proto-oncogene …

Objectives Medullary thyroid carcinoma (MTC) is caused by a malignant transformation in
the parafollicular C-cells of the thyroid, where calcitonin (CT) is released. Nowadays, CT is …

Gender bias in the incidence of thyroid cancer is well known, however, the underlying
mechanism is largely unknown. The current study determines variations in the molecular …